|
March 21, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 1:16 FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy https://www.prnewswire.com/news-releases/fda-expands-approval-of-adcetris-for-first-line-treatment-of-stage-iii-or-iv-classical-hodgkin-lymphoma-in-combination-with-chemotherapy-300617003.html 3:14 Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain https://www.prnewswire.com/news-releases/therapix-biosciences-announces-fda-clearance-of-investigational-new-drug-ind-for-phase-iia-clinical-trial-of-thx-110-in-the-treatment-of-chronic-low-back-pain-300616646.html 5:44 Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce tobacco use, especially among youth, by exploring options to address the role of flavors ‒ including menthol ‒ in tobacco products https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm601690.htm 8:39 Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com. Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/ |